Su-Peng Yeh

CDK1-dependent phosphorylation of EZH2 suppresses methylation of H3K27 and promotes osteogenic differentiation of human mesenchymal stem cells

Yongkun Wei, Ya-Huey Chen, Long‐Yuan Li et al. · Nature Cell Biology · 2010 · 392 citations

Regenerative Medicine, Cdk1-dependent Phosphorylation, Developmental Biology +8

Randomized, Double-Blind, Phase III Trial of Enzastaurin Versus Placebo in Patients Achieving Remission After First-Line Therapy for High-Risk Diffuse Large B-Cell Lymphoma

Michael Crump, Sirpa Leppä, Luis Fayad et al. · Journal of Clinical Oncology · 2016 · 122 citations

Safety and efficacy of talacotuzumab plus decitabine or decitabine alone in patients with acute myeloid leukemia not eligible for chemotherapy: results from a multicenter, randomized, phase 2/3 study

Pau Montesinos, Gail J. Roboz, Claude‐Eric Bulabois et al. · Leukemia · 2020 · 96 citations · Full text

Hematological Malignancy, Medicine, Acute Myeloid Leukemia +5

Ramucirumab plus docetaxel versus placebo plus docetaxel in patients with locally advanced or metastatic urothelial carcinoma after platinum-based therapy (RANGE): overall survival and updated results of a randomised, double-blind, phase 3 trial

Daniel P. Petrylak, Ronald de Wit, Kim N. et al. · The Lancet Oncology · 2019 · 83 citations · Full text

Platinum-based Therapy, Urology, Genitourinary Cancer +8

The oncometabolite R-2-hydroxyglutarate activates NF-κB-dependent tumor-promoting stromal niche for acute myeloid leukemia cells

Jing-Yi Chen, You-Syuan Lai, Hui‐Jen Tsai et al. · Scientific Reports · 2016 · 70 citations · Full text